Matrix Metalloproteinases in Dog Brains Exhibiting Alzheimer‐Like Characteristics

• Published in: Journal of neurochemistry Vol. 68; no. 4; pp. 1606 - 1611
• Main Authors: Lim, Giselle P., Russell, Michael J., Cullen, Michael J., Tökés, Zoltán A.
• Format: Journal Article
• Language: English
• Published: Oxford, UK Blackwell Science Ltd 01.04.1997; Blackwell
• Subjects: Aged; Aged, 80 and over; Alzheimer Disease - enzymology; Alzheimer's disease; Amyloid plaques; Animals; Biological and medical sciences; Brain Chemistry; Canine brain; Collagenases - analysis; Collagenases - metabolism; Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases; Dogs; Enzyme Activation; Female; Gelatin; Gelatinase B; Humans; Male; Matrix Metalloproteinase 9; Medical sciences; Neurology; Fissipedia; Carnivora; Nervous system diseases; Enzyme; Alzheimer disease; Central nervous system; Metalloendopeptidases; Gelatinase B; Cerebral disorder; Peptidases; Vertebrata; Mammalia; Enzymatic activity; Animal; Central nervous system disease; Hydrolases; Degenerative disease; Dog; Brain (vertebrata)
• ISSN: 0022-3042; 1471-4159
• DOI: 10.1046/j.1471-4159.1997.68041606.x

: We have previously reported that the amount of the neuronal matrix metalloproteinase (MMP) MMP‐9, capable of cleaving β‐amyloid1–40 predominantly at Leu34‐Met35, is increased in a latent form in hippocampal specimens from AD patients and have suggested that the lack of activation of this enzyme may contribute to the deposition of β‐amyloid in plaques. The current study addresses whether similar matrix proteinases are detectable in amyloid‐positive and ‐negative brain specimens of aged beagles. Using quantitative zymography, three major neutral proteinases with molecular masses of 60, 95, and 280 kDa were readily detected. These enzymes have the characteristics of MMPs because they were inhibited by EDTA and 1,10‐phenanthroline, and their activities were restored by addition of both Ca2+ and Zn2+. The 95‐ and 280‐kDa proteinases cross‐reacted with specific monoclonal antibodies to human MMP‐9 (gelatinase B; EC 3.4.24.35). Canine MMP‐9 was latent because activation by organomercurial treatment resulted in a characteristic decrease in molecular mass. Statistical analysis revealed no difference in the 60‐kDa proteinase activity in amyloid‐positive and ‐negative brain specimens. However, significantly increased amounts of latent MMP‐9 were observed in amyloid‐positive brain specimens (p≤ 0.05) compared with amyloid‐negative brain specimens. The observations document that changes in MMP‐9 expression in amyloid‐positive beagle brains are similar to those reported in the human Alzheimer's disease hippocampus and suggest the possibility that insufficient activation of MMP‐9 may contribute to β‐amyloid accumulation, a hypothesis that needs to be further investigated.